These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2930112)

  • 21. Comparative efficacy of amoxycillin + clavulanic acid (augmentin), flucloxacillin and vancomycin against S. aureus endocarditis in the rat.
    Catherall EJ; Irwin R; Mizen L
    J Chemother; 1989 Jul; 1(4 Suppl):69-70. PubMed ID: 16312308
    [No Abstract]   [Full Text] [Related]  

  • 22. Nafcillin-induced agranulocytosis.
    Markowitz SM; Rothkopf M; Holden FD; Stith DM; Duma RJ
    JAMA; 1975 Jun; 232(11):1150-2. PubMed ID: 1173618
    [No Abstract]   [Full Text] [Related]  

  • 23. Neutropenia probably resulting from nafcillin.
    Sandberg M; Tuazon CU; Sheagren JN
    JAMA; 1975 Jun; 232(11):1152-4. PubMed ID: 1173619
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of methicillin, nafcillin, and oxacillin in therapy of Staphylococcus aureus endocarditis in rabbits.
    Egert J; Carrizosa J; Kaye D; Kobasa WD
    J Lab Clin Med; 1977 Jun; 89(6):1262-8. PubMed ID: 864305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center.
    Levine DP; Cushing RD; Jui J; Brown WJ
    Ann Intern Med; 1982 Sep; 97(3):330-8. PubMed ID: 7114630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infectious scleritis after a diabetic foot ulcer.
    Maskin SL
    Am J Ophthalmol; 1993 Feb; 115(2):254-5. PubMed ID: 8430739
    [No Abstract]   [Full Text] [Related]  

  • 27. Possible synergy between aminoglycosides and vancomycin in the treatment of Staphylococcus epidermidis endocarditis?
    Plastino KA; Connors JE; Spinler SA
    Ann Pharmacother; 1994 Jun; 28(6):737-9. PubMed ID: 7919563
    [No Abstract]   [Full Text] [Related]  

  • 28. Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations.
    Gopal V; Bisno AL; Silverblatt FJ
    JAMA; 1976 Oct; 236(14):1604-6. PubMed ID: 989135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Right endocarditis caused by Staphylococcus aureus in parenteral drug addicts: evaluation of a combined therapeutic scheme for 2 weeks versus conventional treatment].
    Espinosa FJ; Valdés M; Martín-Luengo F; Arribas JP; Albaladejo J; Pérez-Gracia A; García-Henarejos JA; Martínez-Madrid O; García-Alberola A
    Enferm Infecc Microbiol Clin; 1993 May; 11(5):235-40. PubMed ID: 8324018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial influence of platelets on antibiotic efficacy in an in vitro model of Staphylococcus aureus-induced endocarditis.
    Mercier RC; Dietz RM; Mazzola JL; Bayer AS; Yeaman MR
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2551-7. PubMed ID: 15215108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cefotaxime and nafcillin-tobramycin.
    Berk SL
    Ann Intern Med; 1985 Feb; 102(2):275-6. PubMed ID: 3966772
    [No Abstract]   [Full Text] [Related]  

  • 32. Vancomycin therapy for infective endocarditis.
    Geraci JE; Wilson WR
    Rev Infect Dis; 1981; 3 suppl():S250-8. PubMed ID: 7342289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone.
    Siaperas P; Pefanis A; Iliopoulos D; Katsarolis I; Kyroudi-Voulgari A; Donta I; Karayiannakos P; Giamarellou H
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3531-7. PubMed ID: 11709335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
    Chambers HF; Kartalija M; Sande M
    J Infect Dis; 1995 Apr; 171(4):897-902. PubMed ID: 7706817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Staphylococcus aureus bacteremia and endocarditis.
    Chang FY
    J Microbiol Immunol Infect; 2000 Jun; 33(2):63-8. PubMed ID: 10917874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial effects promoting biofilm formation and persistent disease: the role of a DNA-binding regulator, SarA, in staphylococcal endocarditis.
    Herrmann M
    J Infect Dis; 2014 Apr; 209(8):1153-5. PubMed ID: 24403558
    [No Abstract]   [Full Text] [Related]  

  • 37. Immune complex glomerulonephritis associated with Staphylococcus aureus bacteremia: response to corticosteroid therapy.
    McKinsey DS; McMurray TI; Flynn JM
    Rev Infect Dis; 1990; 12(1):125-7. PubMed ID: 2137252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Staphylococcus aureus prosthetic valve endocarditis.
    Hassoun A
    Am J Med; 2007 Mar; 120(3):e9; author reply e11. PubMed ID: 17349434
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of vancomycin plus tobramycin as antiperitonitis regimen for patients on CAPD.
    Vargemezis V; Thodis E; Pasadakis P; Martinis G; Kousta E
    Adv Perit Dial; 1990; 6():123-5. PubMed ID: 1982788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of ampicillin plus a beta-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus.
    Washburn RG; Durack DT
    J Infect Dis; 1981 Sep; 144(3):237-43. PubMed ID: 6268715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.